Skip to main content

EDITORIAL article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1491644
This article is part of the Research Topic Implications of Immune Landscape in Tumor Microenvironment View all 12 articles

Editorial: Frontiers in Immunology Research Topic: Implications of Immune Landscape in Tumor Microenvironment

Provisionally accepted
Somchai Chutipongtanate Somchai Chutipongtanate 1,2Selvarangan Ponnazhagan Selvarangan Ponnazhagan 3,4Juana Serrano Lopez Juana Serrano Lopez 5*
  • 1 MILCH and Epidemiology, Department of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, OH, United States, Cincinnati, United States
  • 2 Department of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, OH, United States, Cincinnati, United States
  • 3 O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, Birmingham, United States
  • 4 Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, Birmingham, United States
  • 5 Health Research Institute Foundation Jimenez Diaz (IIS-FJD), Madrid, Spain

The final, formatted version of the article will be published soon.

    Keywords: Tumor-immune stromal landscape, Tumor Microenvironment, Next generation tolos, Immune checkpoint blockade, Epigenetic mechanisms regulating immune suppression, ILINCS

    Received: 05 Sep 2024; Accepted: 09 Sep 2024.

    Copyright: © 2024 Chutipongtanate, Ponnazhagan and Serrano Lopez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Juana Serrano Lopez, Health Research Institute Foundation Jimenez Diaz (IIS-FJD), Madrid, Spain

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.